FormWeb • moxetumomab pasudotox-tdfk

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

moxetumomab pasudotox-tdfk

moxetumomab pasudotox-tdfk

Restricted Lumoxiti --> restricted to hospital outpatient oncology.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Lumoxiti	POWDER FOR INJECTION, INTRAVENOUS	1 mg

Comments:

Lumoxiti Medication Guide

Lumoxiti is formulary restricted to hospital outpatient oncology. Rare use is expected; if an inpatient case arises it will be evaluated on a specific basis. Not routinely stocked.

Reviewed: 23 April 2019 (Lumoxiti)

Last updated: Apr. 24, 2019

Black Box Warning: Capillary Leak Syndrome and Hemolytic Uremic Syndrome
Formulary, Not Routinely Stocked: Lumoxiti --> 1 mg

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.